NCT01021202

Brief Summary

The purpose of this study is:

  • to evaluate the optimal time-point for percutaneous dilation tracheostomy in COPD patients in terms of duration on mechanical ventilation, length of stay on ICU and mortality;
  • to evaluate the rate of infections and infectious complications of tracheostomized COPD patients;
  • to evaluate the spectrum of pathogens in tracheostomized and intubated COPD patients;
  • to evaluate the amount of sedatives used in mechanically ventilated COPD patients;
  • to assess the quality of life in COPD patients tracheostomized after 3 or after 10 days.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2009

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 26, 2009

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

July 1, 2022

Status Verified

June 1, 2022

Enrollment Period

4.5 years

First QC Date

October 6, 2009

Last Update Submit

June 29, 2022

Conditions

Keywords

tracheostomytracheotomydilationaldilatativecritical careintensive careCOPDchronic obstructive pulmonary diseaselung diseasepneumoniaprospective studyquestionnairequality of lifeoutcomemortality

Outcome Measures

Primary Outcomes (1)

  • Cumulative duration of mechanical ventilation (in days)

    Cumulative duration of mechanical ventilation (in days)

    Day 1 - 28

Secondary Outcomes (5)

  • All-cause mortality

    Day 28, 90 and end of ICU stay

  • Length of stay on ICU / hospital

    end of ICU / hospital stay

  • Infections (Ventilator-associated pneumonia, spectrum of pathogens in BALF, infectious complications)

    Day 1 - 28

  • Cumulative use of sedatives

    Day 1 - 28

  • Quality of Life - Questionnaire

    discharge from ICU, day 28 and day 90

Study Arms (2)

Early tracheostomy

EXPERIMENTAL

Percutaneous dilation tracheostomy \< 72h on mechanical ventilation

Procedure: Percutaneous dilation tracheostomy

Late tracheostomy

EXPERIMENTAL

Percutaneous dilation tracheostomy \> 10 days on mechanical ventilation

Procedure: Percutaneous dilation tracheostomy

Interventions

Percutaneous dilation tracheostomy using Ciaglia blue rhino system (Cook medical, Limerick, IRELAND). Tracheostomy is conducted by two experienced physicians with (video-)bronchoscopic control and continuous monitoring of ECG, blood pressure, pulse and peripheral oxygen saturation.

Early tracheostomyLate tracheostomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of COPD (GOLD stage III or IV)
  • Suspected long-time invasive mechanical ventilation due to ARF (\> 10 days)
  • Informed consent of the patient or legal guardian

You may not qualify if:

  • Severe neurological failure (such as stroke, cerebral haemorrhage etc.)
  • Immunosuppressant therapy (with the exception of steroid therapy)
  • Major risk of bleeding
  • Intubation \> 72 h
  • Contraindication for dilation tracheotomy
  • Impossibility of intubation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinikum Hamburg - Eppendorf (University Medical Center Hamburg-Eppendorf)

Hamburg, 20246, Germany

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveLung DiseasesPneumonia

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsInfections

Study Officials

  • Stefan Kluge, MD

    Department of Critical Care Medicine, University Medical Center Hamburg - Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2009

First Posted

November 26, 2009

Study Start

October 1, 2009

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

July 1, 2022

Record last verified: 2022-06

Locations